As of August this year, based on Herbalife's most recent financial report, the company's trailing twelve months EPS is $1.6. During 2025, HLF reported a per-share earnings of $2.22, which shows a decline compared to the EPS of $2.53 recorded in 2024. Herbalife's EPS for the quarterly period ending on Jun 30, 2026 came in at -$0.25.
The yearly earnings per share during 2025 was $2.22, a decline of 12.3% compared to $2.53 recorded in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at -$0.25, reflecting a 152.1% decline compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $1.6. During 2024, the annual earnings per share was $2.53, representing an increase of 75.7% compared to 2023.
Herbalife has recorded a decline in earnings per share of 152.1% in the past 12 months (YoY, quarterly). During the past three years, HLF registered an average yearly EPS growth of -12%. Herbalife had an average annual EPS growth of -4.7% in the last five years. Over the last decade, HLF had an average annual earnings per share growth of 0.8%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| HLF Herbalife Ltd | 7.91 | -12.3% | -12% | -4.7% |
| NATR Natures Sunshine Products Inc | 14.06 | 163.4% | N/A | -0.2% |
| NUS Nu Skin Enterprises Inc - Class A | N/A | 210.2% | 15.7% | -2.3% |
| MTEX Mannatech Inc | N/A | -706.1% | N/A | N/A |
| USNA Usana Health Sciences Inc | N/A | -73.6% | -45.6% | -37.1% |
| MED Medifast Inc | N/A | -994.7% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.